Month: September 2021

Categories
Pharmaceutical

Hospital Services Segment Is Expected To Contribute Maximum Market Share In Global Angelman Syndrome Treatment Market

The latest study by Fact.MR- (a leading provider of business and competitive intelligence) on the global Angelman Syndrome Treatment Market survey offers an overall compilation of the historical, current, and future prospects of the Angelman Syndrome Treatment market as well as its factors who are responsible for such a growth in the market for the treatment of Angelman Syndrome.

The Angelman Syndrome Treatment Market survey report provides estimates of the size of the Angelman Syndrome Treatment Market and the total share of major regional segments

Angelman Syndrome Treatment Market: Overview

People with Angelman syndrome generally tend to have a normal life expectancy, but there is no cure for the disorder. Angelman syndrome is caused by the lack of a functional copy of the UBE3A gene, which is inherited from the mother.

It is also estimated that the Angelman Syndrome Treatment market will experience moderate growth over the forecast period. The US Food and Drug Administration recently approved the orphan drug GTX-101 for the treatment of Angelman syndrome.

The Hospital Services segment is expected to contribute maximum market share in the global Angelman Syndrome Treatment Market. Treatment for Angelman syndrome mainly focuses on improving a patient’s symptoms.

To get In-depth Insights Request For Brochure Here – https://www.factmr.com/connectus/sample?flag=B&rep_id=1309

The demand for the Angelman Syndrome Treatment market study encompasses the current market scenario on the global platform, along with the development of the Angelman Syndrome Treatment market during the forecast period.

Using the SWOT analysis, the business study highlights the strengths, weaknesses, opportunities, and threats of each Angelman Syndrome Treatment market participant in a comprehensive manner.

In addition, the Angelman Syndrome Treatment market survey report emphasizes the Angelman Syndrome Treatment market acceptance pattern and demand in various industries.

Angelman Syndrome Treatment Market Report Highlights & Forecasts

• Elaborated scenario of the parent market
• Transformations in the market dynamics of Angelman Syndrome Treatment
• Detailed segmentation of the target market
• Historical, current, and forecast Angelman Syndrome Treatment market size based on value and volume
• Latest industry developments and market trends of Angelman Syndrome Treatment -Competitive Analysis of Angelman Syndrome Treatment Market
• Strategies Adopted by Market Players for Angelman Syndrome Treatment and Product Developments
• Potential and Niche Segments as well as Their Regional Analysis
• Unbiased Analysis of Angelman Syndrome Treatment Market Size

The research report analyzes market demand for Angelman Syndrome Treatment by various segments. Business leaders insight into Angelman Syndrome treatment and how to increase their market share

The report provides a breakdown of the market and its sales, consumption, production analysis and forecasts by categorizing it based on parameters such as type, application / end-user, and region.

This research report contains the analysis and forecast of sales, production, price, market share of Angelman Syndrome Treatment, and growth trends for various products such as:

Angelman Syndrome Treatment Market: Segmentation

For the time being, the global Angelman Syndrome treatment market is segmented by treatment, provider, and geography.

Based on Treatment, the global Angelman Syndrome Treatment Market is segmented into the following segments:

Physiotherapy
Communication
Therapy Behavior Therapy
Others

The Global Angelman Syndrome Treatment Market is segmented by service provider into:

Hospitals
Specialty
Clinics Outpatient Surgical Centers
Others

Regional analysis and forecast

Additionally, this research study on Sale of Angelman Syndrome Treatment analyzes market size, production, consumption, and its advancement trends on the global, regional, and country level, and covers the following regions within its scope:

Geographically, the global Angelman Syndrome Treatment Market is segmented into North America, Latin America, Europe, Asia Pacific ex Japan (APEJ), Japan, and the Middle East and Africa (MEA).

North America and Europe are expected to dominate the global Angelman Syndrome treatment market due to increasing healthcare spending and increasing consumer demand for Angelman Syndrome treatment.

The Asia-Pacific Angelman Syndrome Treatment Market is expected to be the fastest growing market with a maximum CAGR due to the increasing penetration of research activity in this emerging region.

In addition, continuous improvements in health infrastructure are fueling the growth of the Angelman Syndrome treatment market in the Asia-Pacific region. For Latin America and the Middle East and Africa, significant or slow growth is expected in the forecast period.

Request a customized report as per your requirement-  https://www.factmr.com/connectus/sample?flag=RC&rep_id=1309

Why Buy This Report?

Below are the reasons to consider this Angelman Syndrome Treatment market report from Fact.MR – a provider of market research and competitive intelligence:

• This Ultimate Guide will help you stay ahead in the market by providing you with the profiles of the Angelman Syndrome treatment participants, their working methods and decision-making skills.
• The report analyzes various factors acting as drivers and barriers to the development and sale of the Angelman Syndrome Treatment Market worldwide.
• This report not only analyzes the current market situation, but also estimates how the Angelman Syndrome Treatment market will evolve for the estimated time period.
• You can use smart methods and make better decisions by having a clear understanding of customer needs and preferences for the product in a given region.

Competitive Landscape Analysis in the Angelman Syndrome Treatment Market:

To provide decision makers with credible insight into their competitive landscape, the research report for the Angelman Syndrome Treatment Industry research report provides a detailed analysis of the competitive landscape of the Angelman Syndrome market.

The competitive landscape analysis for the Angelman Syndrome Treatment market includes detailed profiles of tier-1, tier-2, and tier-3 players.

The respective Angelman Syndrome Treatment Manufacturers’ market share is presented so that executives can understand the market scenario.

Major hospitals that offer Angelman Syndrome treatment include General Hospital Corporation, Boston Children’s Hospital, Rady Children’s Hospital – San Diego, Angelman Syndrome Foundation, Cincinnati Children’s Hospital Medical Center, and others.

Below are some of the main focuses of this research:

• Provide an in-depth analysis of key operational strategies focusing on corporate structure, R&D strategies, localization strategies, manufacturing capabilities and sales performance of various companies.

• Provide an overview of the product portfolio, including product planning, development and positioning Partnerships
• Discover regional sales activities
• Analyze Angelman Syndrome Treatment market size and provide the forecast for the current and future contraceptive market during the forecast 2018-2028
• Analyze the competitive factors, competitors’ Angelman Syndrome Treatment market shares, product capabilities, and supply chain structures of the Angelman Syndrome Treatment Market.
• In-depth analysis of various Angelman Syndrome Treatment Market insights, namely Angelman Syndrome Treatment Market Trends, Growth Drivers, Opportunities, and other related challenges.
• The ability of suppliers and buyers to make better business decisions.
• The report provides a comprehensive analysis of the key factors anticipated to drive the need for Angelman Syndrome Treatment market. This study also provides a detailed review of the opportunities as well as current trends observed on the sale of the Angelman Syndrome Treatment market.

Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 – https://www.youtube.com/watch?v=MCEzxHyNzHc

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global HIV-associated Nephropathy Treatment Market Size 2021 Global Trends, COVID-19 Update, Business Growth, Top Players Update, Business Statistics And Forecast To 2028

The comprehensive research study report on the Global HIV-associated Nephropathy Treatment Market concentrates on the macro along with microeconomic aspects that are assisting its advancement. The report likewise focuses on the regulative structure that is forming the future of the global market. Furthermore, the research study report likewise makes not of the existing along with dominating prices structure, emerging locations of applications, and impending financial investment chances in the global market.

The report likewise provides an extensive analysis of how the predicted growth aspects will form the marketplace characteristics in the coming years of the forecast duration. Moreover, it likewise offers significant along with actionable insights on the essential trends that are establishing the existing market situation and which will be financially rewarding for the future of the global HIV-associated Nephropathy Treatment market.

The research study report on the global HIV-associated Nephropathy Treatment market likewise supplies an in-detailed analysis of the total supplier landscape. The report evaluates the essential marketing and advertising techniques embraced by the leading business in the global market. Furthermore, it thinks about the existing advancement, previous occasions, and current trends to supply a strong and impartial viewpoint on the future instructions in which these leading business will be heading into.

Get Request for PDF Brochure of This Market Research Report – https://www.factmr.com/connectus/sample?flag=B&rep_id=1303

To back its viewpoint, the research study report covers all the aspects and occasions such as mergers, acquisitions, takeovers, joint endeavors, and tactical alliances. It likewise evaluates the entry barriers and total strength of the competitors in the global HIV-associated Nephropathy Treatment market.

Prominent HIV-associated Nephropathy Treatment market players covered in the report include: ViiV Healthcare, Gilead Sciences, Johnson & Johnson, eNovation Chemicals, Active Biopharma, F. Hoffmann-La Roche Ltd, Boerchem and much more

Insights that HIV-associated Nephropathy Treatment market report consists of:

  1. Segment-smart analysis of global HIV-associated Nephropathy Treatment market
  2. Strategic and brand name positioning of essential market players
  3. Revenue, usage and production patterns
  4. Drivers, trends, and other aspects of growth
  5. Key alliances, R&D advancements, and so on

Global HIV-associated Nephropathy Treatment Market Segmentations

The global HIV-associated nephropathy treatment market can be segmented on the basis of drug type, circulation channel, end users and location.

Based on Drug Type, the global HIV-associated nephropathy treatment market is segmented as:

  • Nucleoside reverse transcriptase inhibitors (NRTIs)
  • Non-nucleoside reverse transcription inhibitors (NNRTIs)
  • Protease inhibitors (PIs)
  • Entry or combination inhibitors
  • Integrase inhibitors (INSTIs)

Based on Distribution Channel, the global HIV-associated nephropathy treatment market is segmented as:

  • Hospital drug store
  • Retail drug store
  • E-commerce

Based on end users, the global HIV-associated nephropathy treatment market is segmented as:

  • Hospital
  • Specialty center
  • Homecare

Get Request For Report Customization –  https://www.factmr.com/connectus/sample?flag=RC&rep_id=1303

The local division is as follows:

  1. North America (U.S. and Canada)
  2. Latin America (Mexico, Brazil, Peru, Chile, and others)
  3. Western Europe (Germany, U.K., France, Spain, Italy, Nordic nations, Belgium, Netherlands, and Luxembourg)
  4. Eastern Europe (Poland and Russia)
  5. Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  6. Middle East and Africa (GCC, Southern Africa, and North Africa)

After checking out the HIV-associated Nephropathy Treatment market report, readers get insight into:

  1. Major chauffeurs and limiting aspects, chances and difficulties, and the competitive landscape
  2. New, appealing opportunities in essential areas
  3. New profits streams for all players in emerging markets
  4. Focus and altering function of different regulative companies in reinforcing brand-new chances in different areas
  5. Demand and uptake patterns in essential markets of the HIV-associated Nephropathy Treatment market
  6. New research study and advancement tasks in brand-new innovations in essential local markets
  7. Changing profits share and size of essential item sections throughout the forecast duration
  8. Technologies and business designs with disruptive capacity

The global HIV-associated Nephropathy Treatment market report provides comprehensive evaluations and quantitative assessments that clarified many essential elements that have actually formed its advancement over the historic duration. In coming years, a few of the essential elements that will form the growth potential customers throughout the forecast duration are objectively covered in the research study.

Some crucial concerns that the HIV-associated Nephropathy Treatment market report attempts to address extensively are:

  1. Key tactical relocations by different players in the HIV-associated Nephropathy Treatment market recently with regard to item launches, offers and tie-ups, and mergers and acquisitions, and divestment of shares.
  2. Which techniques will allow top players in the HIV-associated Nephropathy Treatment market to broaden their geographical footprints?
  3. Which brand-new business designs are anticipated to alter the course of growth of essential local markets in future?
  4. Which innovations will witness most appealing research study financial investments and what will be the essential sources of financing for start-ups and brand-new entrants?
  5. Which items sections have in current years have seen brand-new, financially rewarding application locations?

Choosing Fact.MR – Reasons to Stay Ahead of the Curve

  1. Provides most current and extensive information of market trends
  2. Provides round the clock assistance to customers for fool evidence services
  3. Provides aid with supply chain enhancement
  4. Provides ideal, ingenious, and feasible business services
  5. Provides customized or tailor made reports to fit the vibrant and particular requirements of customer.

Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 – https://www.youtube.com/watch?v=MCEzxHyNzHc

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Increase In Infectious Diseases Expected To Drive Revenue Growth Of Bacterial Antigens Market

The Report on Bacterial Antigens market discusses the possible outcomes of investment in certain strategies that can be adopted during the forecast period for generating revenues. We at Fact.MR is providing digitalization tools for gathering innovative ideas and interesting insights related to the market.

Such vital information will help investors accordingly take action. The main objective of the report is to draw a basic outline of the Bacterial Antigens market and describe its classification.

The global Bacterial Antigens market is replete with new growth opportunities and expansion avenues. There has been an increase in the use of products and services falling under the ambit of Bacterial Antigens, giving a thrust to the growth of the global Bacterial Antigens market.

REQUEST A FREE DEMO OF REPORT- https://www.factmr.com/connectus/sample?flag=B&rep_id=1301

The unprecedented use of these products can be attributed to the increasing paying capacity of the masses. Furthermore, in the absence of robust or utilitarian alternatives, the demand within the global Bacterial Antigens market is projected to reach new heights of recognition.

It is worthwhile to mention that the global Bacterial Antigens market is treading along a lucrative pathway due to favorable government legislations.

Bacterial Antigens Market: Segmentation

Tentatively, the global bacterial antigens market can be segmented on the basis of product type, pathogen type, application, end user and geography.

Based on product type, the global bacterial antigens market is segmented into:

  • Chlamydia trachomatis
  • Native Chlamydia trachomatis
  • Clostridium difficile Toxoid A
  • Clostridium difficile Toxoid B
  • Native Lipoteichoic Acid
  • Neisseria gonorrhoeae
  • Recombinant Protein G
  • Trichomonas vaginalis

Based on pathogen type, the global bacterial antigens market is segmented into:

  • Inactivated Pathogen
  • Purified Pathogen

Based on application type, the global bacterial antigens market is segmented into:

  • ELISA
  • Immunoassay
  • SDS-PAGE
  • Hemagglutination
  • Agglutination test

Based on end user, the global bacterial antigens market is segmented into:

  • Hospital Associated Diagnostic Laboratories
  • Diagnostic Laboratories and Centers
  • Academic and Research Institutes

The Bacterial Antigens market report answers some important questions such as:

  • Who are the top players of this market?
  • Which is the leading segment in this market?
  • Which region earned the largest share in the Bacterial Antigens market and why?
  • What is the future prospect of this market?

Bacterial Antigens Market: Key Players

The global bacterial antigens market is highly fragmented owing to the presence of large number of domestic manufacturers. Examples of some of the key players operating in the global bacterial antigens market are Bio-Rad Laboratories, Inc., Creative Diagnostics, Enzo Life Sciences, Inc., The Native Antigen Company Ltd., Jena Bioscience GmbH, QED Bioscience Inc., Ross Southern Laboratories and others.

REQUEST FOR CUSTOMIZATION – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1301

The report will help readers to:

  • A clear understanding of the market and its growth trajectories such as drivers, restraints, challenges, and upcoming opportunities.
  • Study the key regions holding notable shares in the global Bacterial Antigens market growth.
  • Discuss the current trends, revenue generation pattern, detailed segmentation, and names of leading segments with attributed factors.

The Bacterial Antigens Market Report Highlights :

  • A detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Bacterial Antigens Market: Regional Outlook

Geographically, the global bacterial antigens market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA).

North America is expected to be the leading market in the global bacterial antigens market owing to the rise in number of research applications of bacterial antigens coupled with increased set up of advanced diagnostic laboratories in the region as compared to other regions.

The bacterial antigens market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the high presence of domestic players manufacturing bacterial antigens to be used to perform immunoassays and agglutination tests along with increased production of variant bacterial antigens by these key domestic players.

Europe is expected to register second largest share in the global bacterial antigens market throughout the forecast period owing to increased presence of bacterial antigen distributors and suppliers across the region.

Bacterial Antigens Market: Drivers

The growing demand for bacterial antigens capable of eliciting a protective immune response against various cancers and infectious diseases is expected to be the major factor driving the growth of the bacterial antigens market over the forecast period.

Also, rapid discovery of novel antigens that can trigger a cross-protective immune response in a bacterial pathogen, growing incidences of cancer and infectious diseases and increase in diagnosis of various diseases are some of the factors further expected to drive the revenue growth in global bacterial antigens market

Why choose Fact.MR ?

Fact.MR not only provides market figures and discusses the key segments but also provides more input into the past and future of this market. In addition, we also provide:

  • Current trends and innovations listed in the various markets and their impact on the competition
  • Launch of new products or technologies and an overall multi-disciplinary approach for accurate insights
  • Data collected from various primary and secondary research sources.
  • Additional information for precise analysis
  • Various analysis methods to deliver precise market information.
  • Round-the-clock availability to serve clients across the world.

Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 – https://www.youtube.com/watch?v=MCEzxHyNzHc

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Thermasonic Ultrasound Gel Warmers Market Sales Witness Incremental Dollar Opportunity During Forecast Period 2021- 2031

The Report on Thermasonic Ultrasound Gel Warmers market discusses the possible outcomes of investment in certain strategies that can be adopted during the forecast period for generating revenues. We at Fact.MR is providing digitalization tools for gathering innovative ideas and interesting insights related to the market.

Such vital information will help investors accordingly take action. The main objective of the report is to draw a basic outline of the Thermasonic Ultrasound Gel Warmers market and describe its classification.

The global Thermasonic Ultrasound Gel Warmers market is replete with new growth opportunities and expansion avenues. There has been an increase in the use of products and services falling under the ambit of Thermasonic Ultrasound Gel Warmers, giving a thrust to the growth of the global Thermasonic Ultrasound Gel Warmers market.

Thermasonic Ultrasound Gel Warmers Market: Overview

The global market for thermasonic ultrasound gel warmers is highly fragmented with a plethora of manufacturers dotting the scene. The thermasonic ultrasound gel warmers market trends include a manufacturing shift in favor of developing regions of Asia Pacific, especially China.

Attributing to stiff competition, manufacturers are now placing emphasis on warranty, quality and technology over price. The market also represents a high volume low value market, which is hampering the market growth.

REQUEST A FREE DEMO OF REPORT- https://www.factmr.com/connectus/sample?flag=B&rep_id=1299

The unprecedented use of these products can be attributed to the increasing paying capacity of the masses. Furthermore, in the absence of robust or utilitarian alternatives, the demand within the global Thermasonic Ultrasound Gel Warmers market is projected to reach new heights of recognition.

It is worthwhile to mention that the global Thermasonic Ultrasound Gel Warmers market is treading along a lucrative pathway due to favorable government legislations.

Thermasonic Ultrasound Gel Warmers Market: Segmentation

The global thermasonic ultrasound gel warmers market can be segmented on the basis of components, applications, end users and regions.

Based on operations, the global thermasonic ultrasound gel warmers market can be segmented into,

  • Manual
  • Automated and Programmable

Based on utility, the global thermasonic ultrasound gel warmers market can be segmented into,

  • Portable With Battery
  • Stationary Without Battery

Based on end users, the global thermasonic ultrasound gel warmers market can be segmented into:

  • Hospitals
  • Diagnostic Labs
  • Ambulatory Surgical centers
  • Home Setting

The Thermasonic Ultrasound Gel Warmers market report answers some important questions such as:

  • Who are the top players of this market?
  • Which is the leading segment in this market?
  • Which region earned the largest share in the Thermasonic Ultrasound Gel Warmers market and why?
  • What is the future prospect of this market?

Thermasonic Ultrasound Gel Warmers Market: Market Participants

Examples of some of the major players operating in the global thermasonic ultrasound gel warmers market include Parker Laboratories, Inc., Nissha Co., Ltd., NEXT Medical Products Company, Scorpia India Medicare Pvt. Ltd., Performance Health, Jorgensen Labs, Whitehall Manufacturing and others.

Request For Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1299

The report will help readers to:

  • A clear understanding of the market and its growth trajectories such as drivers, restraints, challenges, and upcoming opportunities.
  • Study the key regions holding notable shares in the global Thermasonic Ultrasound Gel Warmers market growth.
  • Discuss the current trends, revenue generation pattern, detailed segmentation, and names of leading segments with attributed factors.

The Thermasonic Ultrasound Gel Warmers Market Report Highlights :

  • A detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Thermasonic Ultrasound Gel Warmers Market: Regional Outlook

The global thermasonic ultrasound gel warmers market can be classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.

The Asia Pacific excluding Japan region is the largest market for global thermasonic ultrasound gel warmers, owing to the large number of ultrasound procedures conducted in the region.

The growing number of hospitals and diagnostics labs in the region is propelling the market growth, which can be attributed to the low cost of manufacturing in these regions. China is expected to spearhead market growth, followed by India, Vietnam, Indonesia and others.

North America, dominated by the U.S., accounts for the second largest share of the global thermasonic ultrasound gel warmers market. North America is estimated to be followed by Europe, which is led by Germany, France and others. However, growth in the developed markets is expected to be stagnant and the rate of growth is expected to be relatively slow.

The Middle East and Africa thermasonic ultrasound gel warmers market is expected to create the highest market opportunity, owing to the growth in ultrasound testing in these regions. The Middle East and Africa market is dominated by the gulf economies of Saudi Arabia, Kuwait, and Qatar.

Why choose Fact.MR ?

Fact.MR not only provides market figures and discusses the key segments but also provides more input into the past and future of this market. In addition, we also provide:

  • Current trends and innovations listed in the various markets and their impact on the competition
  • Launch of new products or technologies and an overall multi-disciplinary approach for accurate insights
  • Data collected from various primary and secondary research sources.
  • Additional information for precise analysis
  • Various analysis methods to deliver precise market information.
  • Round-the-clock availability to serve clients across the world.

Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 – https://www.youtube.com/watch?v=MCEzxHyNzHc

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Benign Positional Vertigo Treatment Market Experience Rapid Growth And Show Prominent Increase During Coming Years

The Fact.MR report offers insight into the Competitive Dynamic in Benign Positional Vertigo Treatment Market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research investments, of each prominent player.

The key factors that shape the entry barrier and intensity of competition in the Benign Positional Vertigo Treatment market are presented in the analysis. Further, the study provides PESTLE analyses of numerous players and an evaluation of how the competitive landscape will evolve over the forecast period 2018 to 2028

Benign Positional Vertigo Treatment Market: Overview

According to the International Headache Society and German National Telephone Health Interview Survey 2003, 243 of 1,003 (24%) participants with moderate dizziness/vertigo had a history of vestibular vertigo and 80 (8%) fulfilled the diagnostic criteria for benign positional vertigo (56 women and 24 men; aged 28–82?years). Lifetime prevalence was 3.2% in females, 1.6% in males and 2.4% overall.

Medical consultation for benign positional vertigo treatment was reported by 78% of individuals. The 1?year incidence was calculated as 0.6%. Patients usually are seen to prefer internal/general medicine (82%), otolaryngology (57%) and neurology (47%) for benign positional vertigo treatment. As per an article from the International Headache Society survey 2003, 1.1?

Request For A Brochure https://www.factmr.com/connectus/sample?flag=B&rep_id=1292

The detailed assessments focus on, inter alia, on the regulatory and macroeconomic frameworks, prevailing pricing structure, imminent investment pockets, and emerging application areas.

Taking the analysis further, the study helps readers get a better understanding of the trends characteristics of the emerging markets, including government regulations crucial to growth of such markets. Shares of major regional markets are also presented in the analysis.

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

Benign Positional Vertigo Treatment Market: Drivers and Restraints

The growing number of cases of benign positional vertigo is driving the growth of the benign positional vertigo treatment market. Rapid turnaround time, lower cost of procedure over conventional methods also fuel the growth of the benign positional vertigo treatment market.

Also, the varied application of benign positional vertigo testing procedures in analyzing/tracking the inner ear and central nervous system and increasing adoption of the treatments in the routine check-ups are harnessing the growth of the benign positional vertigo treatment market.

However, lack of awareness regarding benign positional vertigo treatments is expected to restrain the growth of the benign positional vertigo treatment market.

Request Customized– https://www.factmr.com/connectus/sample?flag=RC&rep_id=1292

Benign positional vertigo treatment Market: Regional Outlook

Geographically, the global benign positional vertigo treatment market is segmented into regions viz. North America, Europe, Asia-Pacific excluding Japan, Middle East and Africa and Japan.

North America & Europe regions are expected to have healthy growth in terms of revenue due to increased awareness regarding benign positional vertigo treatment as a part of the routine checkups.

Besides, the lower cost of the procedure compared with other alternative treatments and low risk associated with the procedure are boosting the growth of benign positional vertigo treatment market in the regions.

Benign positional vertigo treatment Market: Key Players

Examples of some of the players identified in the benign positional vertigo treatment market include AstraZeneca plc., Intas Pharmaceutical Ltd., Cadila Pharmaceuticals, Pfizer Inc., Sanofi S.A., Medichem S.A., Liaoyuan Silver Eagle Pharmaceutical Co., Ltd., LGM Pharma, Marclabs and Sun Pharmaceutical Industries Ltd.

Benign positional vertigo treatment market: Segmentation

Tentatively, the benign positional vertigo treatment market has been segmented on the basis of the drug class, distribution channel, age group, and geography.

Based on drug class type, the benign positional vertigo treatment market is segmented as:

  • Anti-histamine
  • Anti-cholinergic
  • Anti-depressant

Based on the distribution channel, the benign positional vertigo treatment market is segmented as:

  • Hospital Pharmacy
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacy

Based on age group, the benign positional vertigo treatment market is segmented as:

  • Pediatrics
  • Adults
  • Geriatrics

Why Choose Fact.MR?

  1. Deliver updated information on the current industry trends
  2. Available 24/7 to facilitate clients with unbiased solutions
  3. Embrace digital technologies to offer accurate business ideas
  4. Exhaustive supply chain augmentation analysis
  5. Provide reports strictly according to the requirements of the clients

Free Mindfulness Meditation Apps to Gain Trajectory Boost during 2021-2031 – https://www.youtube.com/watch?v=MCEzxHyNzHc

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Why are Enzymatic Assay-Based Newborn Screening Consumables Gaining Traction : Check Fact.MR’s Latest Study

Award-winning consulting firm Fact.MR’s recent report on the newborn screening market forecasts an optimistic outlook, predicting a CAGR surpassing 8% to reach a valuation of over US$ 1 billion by 2031. Increased spending on infant care in the wake of accelerating birth rates is principally driving demand for newborn screening solutions.

The market posted impressive gains in the past, expanding at under 8% CAGR from 2016 to 2020. Stakeholders have been inclining specifically towards the use of newborn screening consumables to predict highly accurate outcomes and growing hygiene concerns associated with reusable screening products.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=6323

According to the World Health Organization, the world has seen a dramatic reduction to the tune of 60% in the under-five category, from 93 deaths per 1,000 live births in 1990 to 38 in 2019. However, global burden of child and youth death remains high, with over 7 million children, adolescents, and youth aged 0-14 years succumbing to preventable diseases. Consequently, governments across key regions are spending on improving existing infant care infrastructure, prompting the entry of key newborn screening solutions providers.

Key Takeaways from Market Study

  • By product, newborn screening consumables to expand impressively, growing at approximately 8% CAGR through 2031
  • Demand for newborn immunoassays & enzymatic screening tests to expand at nearly 7% CAGR over the next ten years
  • By test, dry blood spot tests to experience high demand, expanding at around 9% CAGR through 2031
  • The U.S. to open up positive expansion prospects, with the market likely to expand at approximately 5% CAGR from 2021 to 2031
  • Rising infant mortality rates to bolster growth prospects for India, expected to generate 30% of overall revenue
  • China to account for 50% of demand amid high uptake of congenital hypothyroidism (CH) and phenylketonuria (PKU) diagnosis

“High concentration of infant population across key emerging economies are attracting a plethora of newborn screening service providers across major countries, poised to generate new revenue streams in the future,” comments a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=6323

Key Market Segments Covered

  • Product
    • Newborn Screening Instruments
      • Disorder Screening Instruments
        • Fully Automated Newborn Screening Instruments
        • Other Newborn Screening Instruments (Semi-automated Instruments, Shakers, Incubators, etc.)
      • Hearing Screening Instruments
        • Newborn Screening Accessories
        • Newborn Screening Devices
      • Pulse Oximeters
    • Consumables
      • Newborn Screening Assay Kits & Reagents
      • Other Newborn Screening Consumables (Columns and Screening Cards)
  • Test Type
    • Dry Blood Spot Newborn Screening Tests
    • Newborn Hearing Screening Tests
    • Critical Congenital Heart Disease (CCHD) Screening Tests
  • Technology
    • Newborn Immunoassays & Enzymatic Screening Tests
    • Tandem Mass Spectrometry
    • Molecular Assays
    • Newborn Hearing Screening Technologies
    • Pulse Oximetry
    • Other Newborn Screening Technologies (Fluorescence, Gel Electrophoresis, etc.)
  • End User
    • Newborn Screening at Clinical Laboratories
    • Newborn Screening at Hospitals
  • Region
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Rest of Europe
    • East Asia
      • China
      • Japan
      • South Korea
    • South Asia
      • India
      • ASEAN
      • Rest of South Asia
    • Oceania
      • Australia
      • Rest of Oceania
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA

Full Access of this Report Is Available at https://www.factmr.com/checkout/6323

Competitive Landscape

Prominent newborn screening providers are reliant on such key expansion strategies as product portfolio expansion by virtue of new releases, acquisition of existing manufacturers and entering into strategic agreements and collaborations. These measures help existing providers secure a firm footing in the market.

  • For instance, Bio-Rad Laboratories offers the VARIANTnbs automated newborn screening for sickle cell disease and other hemoglobin disorders, featuring fully automated analysis and advanced result reporting for maximum efficiency. It uses dried blood spot specimens to provide results.
  • Recently, in May 2021, Baebies was awarded US$ 2.7 million in a Phase-II B SBIR grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) which supports validation, clinical evaluation and FDA submission of a rapid test panel for near-patient heparin monitoring.

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the newborn screening market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (instruments and consumables), test (dry blood spot tests, hearing screening tests, and CCHD screening tests), technology (immunoassays & enzymatic tests, tandem mass spectrometry, molecular assays, hearing screening technologies, pulse oximetry, and others [fluorescence, gel electrophoresis, etc.]), and end user (clinical laboratories and hospitals), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

For More Insights https://www.biospace.com/article/atrial-fibrillation-stroke-treatment-market-players-are-collaborating-with-heart-research-associate-to-offer-enhanced-version-of-medication-says-fact-mr/

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Sales of Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets Is Likely to Expand at under 5% CAGR until 2031

According to a recently published report by award-winning consulting firm Fact.MR. Heavy emphasis on herbal-based and traditional medicines is anticipated to account for bulk of this expansion.The market for rhizoma gastrodiae tablets in the U.S is likely to expand at under 5% CAGR until 2031.

Historically, the market accrued credible gains, expanding at just under 10% CAGR from 2016 to 2020. Prospects have been further heightened amidst the COVID-19 crisis, with several healthcare providers investigating the possibility of incorporating alternative medicine as an effective first-line treatment for severely infected patients.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=6322

As per the World Health Organization, maximum application has been in China, attributed to growing application of Traditional Chinese Medicine (TCM) to treat debilitating diseases such as severe acute respiratory syndrome (SARS). Furthermore, 4 out of 5 healthcare providers in key African countries have embedded alternative medicine as an effective therapy. Moreover, applications have also widened to treat various chronic disorders, including fatty liver.

Key Takeaways from Market Study

  • Gastrodia elata f. glauca rhizoma gastrodiae tablet demand to expand at an impressive 10% CAGR
  • By distribution channel, retail pharmacies to account for maximum sales, expanding at a CAGR of approximately 15%
  • Sales of rhizoma gastrodiae tablets in the U.S. to generate approximately 40% of revenue, expanding at under 5% CAGR
  • China to remain the epicenter of market growth, yielding over 50% of total revenue
  • 3 out 10 rhizoma gastrodiae tablet sales are expected across India, expanding at a CAGR of 9%
  • Market in the U.K. to emerge as a promising hub, poised to exhibit a CAGR of approximately 7% through 2031

“Prominent manufacturers of rhizoma gastrodiae tablets are likely to majorly incline towards key emerging economies across Asia and Africa, amid heightened scope of traditional medicine in key countries,” concludes a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=6322

rhizoma gastrodiae tablets market

Key Market Segments Covered

  • Type
    • Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets
    • G. Elata Bl. F. Elta Rhizoma Gastrodiae Tablets
    • Other Rhizoma Gastrodiae Tablets
  • Distribution Channel
    • Rhizoma Gastrodiae Tablets for Hospital Pharmacies
    • Rhizoma Gastrodiae Tablets for Retail Pharmacies
    • Rhizoma Gastrodiae Tablets for Online Pharmacies
  • Region
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Spain
      • Italy
      • Rest of Europe
    • East Asia
      • China
      • Japan
      • South Korea
      • Rest of East Asia
    • South Asia
      • India
      • ASEAN
      • Rest of South Asia
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA
    • Oceania
      • Australia & New Zealand
      • Rest of Oceania

Full Access of this Report Is Available at https://www.factmr.com/checkout/6322

Competitive Landscape

Prominent rhizome gastrodiae tablet manufacturers as profiled in Fact.MR’s report include Zhaotong Huacheng Pharmaceuticals, Guangdong Luofu Shan National Pharmaceutical Co. Ltd., Beijing Tong Ren Tang, Guizhou Bailing Group,Guangxi Changzhou Natural Pharmaceutical Co. Ltd., Lanzhou Foci Pharmaceutical, Shaanxi Tianyang Pharmaceutical, Taiji Group Sichuan Mianyang Pharmaceutical,and Tsumura & Co.

  • In June 2017, Beijing Tong Ren Tang Europe Holding B.V entered a strategic co-operation agreement with the Republic of Kazakhstan for establishing a Chinese Medical Center to further Chinese Medicine.
  • In November 2019, Tsumura & Co. concluded its Letter of Intent regarding Tianjin China Medico Technology Co. Ltd. to forge a capital alliance with the intention of expanding its business in Traditional Chinese Medicine and ensure stable supply of crude drugs.

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the rhizoma gastrodiae tablets market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (Gastrodia Elata F. Glauca, G. Elata Bl. F. Elata, and others) and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

For More Insights https://www.biospace.com/article/acquired-cystic-kidney-disease-treatment-demand-fuelled-by-increased-r-and-d-activities-says-fact-mr/

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

How are Pooled Donor Human Umbilical Vein Endothelial Cells (HUVEC)Generating Demand : Fact.MR

Award-winning consulting firm Fact.MR’s report on the global human umbilical vein endothelial cells (HUVEC) market forecasts a healthy growth trajectory for the 2021-2031 forecast period. According to the study, rapid advancements in biotechnology and genetic engineering are opening up new growth avenues for advanced disease treatment, particularly across areas such as oncology. Demand for human umbilical vein endothelial cell-based treatment has been gradually gaining momentum, as advancements in genetic engineering and biotechnology become increasingly overt.

As per data published by GLOBOCAN, global cancer burden rose to 19.3 million cases, while associated fatalities increased to 10 million by 2020. Amongst all the cancers, breast cancer accounts for nearly a quarter of the total cases diagnosed every year. Hence, healthcare providers are incorporating highly advanced therapeutic approaches, thereby widening the growth prospects for human umbilical vein endothelial cells.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=6216

Manufacturers are directing bulk of their investments across key regions such as China, India, and other countries in Asia Pacific. Over the years, these countries have witnessed unprecedented expansion of their existing healthcare infrastructure. This is majorly attributed to the presence of a huge population base, necessitating delivery of advanced healthcare for various chronic and infectious diseases.

Key Takeaways from Market Study

  • By type, pooled donor-derived HUVECs are expected to experience elevated sales through 2031
  • Oncology to emerge as a highly promising application area for HUVEC-based treatment
  • The U.S. to generate multiple revenue streams for the market, across CVD treatment, oncology, and angiogenesis
  • Extensive development of biotechnology and cell culture studies driving demand across India

“Rapid advancements in healthcare are prompting developments across key therapeutic areas, providing enough room for the proliferation of HUVEC-based therapeutics,”remarks a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=6216

human umbilical vein endothelial cells huvec market

Key Market Segments Covered

  • Type
    • Single Donors of Human Umbilical Vein Endothelial Cells
    • Pooled Donors of Human Umbilical Vein Endothelial Cells
  • Application
    • Human Umbilical Vein Endothelial Cells for Wound Healing
    • Human Umbilical Vein Endothelial Cells for Angiogenesis
    • Human Umbilical Vein Endothelial Cells for Tissue Engineering
    • Human Umbilical Vein Endothelial Cells for Inflammation Treatment
    • Human Umbilical Vein Endothelial Cells for Oncology
    • Human Umbilical Vein Endothelial Cells for Other Applications
  • Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K
      • Italy
      • Russia
      •  Nordics
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • Rest of Asia Pacific
    • Latin America
      • Mexico
      • Brazil
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • Turkey
      • Rest of MEA

Full Access of this Report Is Available at https://www.factmr.com/checkout/6216

Competitive Landscape

Prominent HUVEC providers as profiled by Fact.MR include Lonza Group AG, PromoCell- Human Centered Science, Merck & Co. KGaA, Thermo Fisher Scientific, Lifeline, and Corning Inc. Due to the presence of such a handful of service providers, the market appears highly consolidated.

  • In May 2021, Merck & Co. announced 40 abstracts, seven oral presentations and seven poster discussions from company and investigator sponsored studies and external collaborations for its oncology treatment furtherance, an initiative which will likely provide tailwinds to its HUVEC portfolio.
  • In January 2021, PromoCell received the EXCiPACTTM certification scheme for pharmaceutical excipients to Good Manufacturing Practice (GMP) standards, which implied that the company can provide tailor-made cell culture media and reagents based on each client’s end user requirements.

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the human umbilical vein endothelial cells market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (single donors and pooled donors) and application (wound healing, angiogenesis, tissue engineering, inflammation, oncology, and others), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

For More Insights https://www.biospace.com/article/cell-proliferation-market-players-are-relying-on-partnerships-and-alliance-to-speed-up-r-and-d-study/

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

sales of Nizatidine Capsules are Expected to Witness Credible Upsurge at Over 10% CAGR: Report Fact.MR

Award-winning consulting firm Fact.MR’s recently published report on the global nizatidine market for the forecast period 2021-2031 expects an optimistic future outlook, projecting noteworthy growth for the said period. Growth is expected to be primarily fueled by extensive application in gastric disorder treatment. sales of nizatidine capsules are expected to witness credible upsurge at over 10% CAGR, attributed to their ease of swallowing and presence of low odor and pleasant taste.

According to a study published by a group of researchers at the University of Gothenburg, nearly 40% of adults suffer from a functional gastrointestinal disorder in a 73,000 person, 33 country survey. Functional gastrointestinal disorders represent a series of chronic disorders in the gastrointestinal tract that often include severe symptoms such as heartburn, acid reflux, and dyspepsia in the upper gastrointestinal tract.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=6217

The market experienced hiccups in the recent past amid a series of product recalls by prominent manufacturers due to several compliance incompatibilities. However, these withdrawals have been overturned, reopening growth frontiers. For instance, in September 2020, Amneal Pharmaceuticals Inc. announced that its nizatidine oral solution 15 mg/ml was available for reorder across the U.S., meeting all FDA requirements.

Key Takeaways from Market Study

  • By type, nizatidine capsules of doses of 150 mg and 300 mg to remain most preferred
  • Retail and online sales of nizatidine products to experience massive incline over coming years
  • Resumption of regulatory approval grants to stimulate nizatidine sales across the U.S.
  • India to attract significant investments, attributed to high domestic manufacturing capabilities of generic drugs
  • China to generate high demand amid rising prevalence of gastric cancer and irritable bowel syndrome

“Surging healthcare costs associated with availing high-grade gastrointestinal disorder treatment are prompting a shift towards consuming orally administered nizatidine capsules and tablets,”says a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=6217

Key Market Segments Covered

  • Type
    • Nizatidine Capsules
    • Nizatidine Tablets
    • Other Nizatidine Types
  • Application
    • Nizatidine for Hospital Pharmacies
    • Nizatidine for Retail Pharmacies
    • Nizatidine for Online Pharmacies
  • Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA

Full Access of this Report Is Available at https://www.factmr.com/checkout/6217

Competitive Landscape

Major players in the market that are associated with offering nizatidine-based formulations and nizatidine, in itself, include Flynn Pharma, MedChemExpress, Mylan N.V., Glenmark Pharmaceuticals, Weightech (Hunan) Pharmaceutical, Hengdian Group, Dr. Reddy’s Laboratories, Eli Lily and Company, and Strides Pharma Science Limited.

These aforementioned players largely concentrate on offering different formulations of nizatidine so as to especially cater to gastrointestinal ailments. A majority of these players are scrambling to acquire regulatory approvals from appropriate authorities to secure a firm footing in the market across regions and increased their revenue and profit margins.

For More Insights https://www.biospace.com/article/polycystic-kidney-disease-treatment-demand-fuelled-by-rising-instances-of-adpkd-across-the-world-says-fact-mr/

More Insights on the Nizatidine Market

Fact.MR, in its new offering, presents an unbiased analysis of the nizatidine treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (capsules, tablets, and others) and application (hospital pharmacies, retail pharmacies, and online pharmacies) across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The report provides qualitative and quantitative information on various players in this market. This report also tracks the market by both, supply side and demand side trends.

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Chronic Radiation Dermatitis Treatment Products Market :Demand for Topical Hydrophilic Creams Expected to Incline Massively through 2031

Fact.MR’s recent report on the global radiation dermatitis treatment market forecasts a healthy growth pace, expecting a revenue share of nearly US$ 700 million by 2031, with an estimated CAGR of around 5% throughout the 2021-2031 forecast period. Increased frequency of radiation-based cancer treatment is attributed to be the chief growth driver for this market.

According to the report, the market accrued significant past gains, reaching around US$ 400 million in value as of 2019. Growth is especially forecast to remain strongest across Asia Pacific, with countries such as China and India emerging at the forefront amid swift advancements in oncology. Approaches such as Traditional Chinese Medicine (TCM) are grabbing major eyeballs.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=5945

Manufacturers are investing in a slew of innovative treatment approaches, including the introduction of film-forming gels. For instance, Switzerland-based Stratpharma has introduced its StrataXRT­­® film-forming wound dressing gel that easily spreads across the affected site in minimal quantities. StrataXRT film-forming gel dries as a thin, flexible, and protective layer, which is gas permeable, waterproof, inert, and devoid of any measurable pH value. The formulation promotes a moist wound healing environment. Companies are taking cues from such developments to manufacture film-forming gels that provide symptomatic relief from acute inflammatory response, discomfort, and itching.

Key Takeaways from Market Study

  • By product, demand for topical hydrophilic creams expected to incline massively through 2031
  • Topical corticosteroid medications to witness impressive uptake over coming years
  • By distribution channel, retail pharmacies to remain dominant, online pharmacies surging in popularity
  • The U.S. to emerge as a potentially lucrative market amid high skin cancer prevalence and treatment rates
  • India to emerge as a promising market for radiation dermatitis treatment in future
  • High adoption of Traditional Chinese Medicine (TCM) to elevate China’s growth prospects

“Multiple wound care and management practices are spurring innovations in the radiation dermatitis treatment domain, prompting key market players to introduce highly novel therapeutic approaches, widening growth prospects,” says a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=5945

Key Market Segments Covered

  • Product
    • Oral Medication-based Radiation Dermatitis Treatment
      • Corticosteroids
      • Oral Analgesics & Antibiotics
    • Topical Radiation Dermatitis Treatment
      • Corticosteroids
      • Hydrophilic Creams
      • Topical Antibiotics
    • Dressing-based Radiation Dermatitis Treatment
      • Hydrogel
      • Hydrocolloid
      • No Sting Barrier Film
      • Honey Impregnated Gauze
      • Silicone Coated Dressing
      • Others
  • Distribution Channel
    • Radiation Dermatitis Treatment through Hospital Pharmacies
    • Radiation Dermatitis Treatment through Retail Pharmacies
    • Radiation Dermatitis Treatment through Online Pharmacies
  • Region
    • North America
      • U.S
      • Canada
    • Europe
      • Germany
      • U.K
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA

Full Access of this Report Is Available at https://www.factmr.com/checkout/5945

Competitive Landscape

Prominent radiation dermatitis treatment players include 3M Company, Molnlycke Health Care AB, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTech Group Plc, and BMG PHARMA S.p.A, among others. Major expansion strategies involve new product launches, acquisitions, and collaborations.

  • In February 2020, Integra Lifesciences launched the AminoExcel® Plus Placental Allograft Membrane, an advanced wound care offering to support soft tissue repair. AmnioExcel Plus is a next generation, thicker, tri-layer, non-side specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds.
  • In January 2020, ConvaTech Group released the ConvaMaxTM superabsorber wound dressing used for the management of highly exuding wounds, including leg ulcers, pressure ulcers, diabetic foot ulcers and dehisced surgical wounds. The product helps manage excess moisture to help protect skin integrity, available in silicone adhesive and non-adhesive forms.

For More Insights https://www.biospace.com/article/emergence-of-pharma-tech-and-new-product-launches-is-driving-growth-of-global-analytical-gel-permeation-chromatography-market-notes-fact-mr/

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the radiation dermatitis treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (oral medication, topical, and dressings) and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com